IMSA_Nvaigation_bar
IMSA_header

Media Page

For Pertinent healthcare information please refer to our library pages.

Launch of IMSA NHI Project: NHI policy briefs and NHI Web library. 28th May, 2009

PDF logoPresentation: Prof Heather McCleod
PDF logoNational Health Insurance in SA: An Introduction for Journalists
PDF logoIMSA NHI Project Media Release

Click through to IMSA NHI Library

Deloitte Study: The Economic & Socio Economic benefits of the R&D based multinational pharmaceutical Companies on the South African Economy.

PDF logoDeloitte Report (Slides)
pdf logoDeloite Report (Document)
pdf logoSector Fact Sheet

IMSA Executive: 2010 - 2011

· John Fagan (Sanofi-aventis) – IMSA Chairperson

· John Norman (Nycomed)- IMSA Vice-Chair

· Ann-Marie Hosang-Archer (Lilly)

· Anne Gillman (GE Healthcare)

· Brian Daniel (Pfizer)

· Paul Stewart (Boehringer-Ingelheim)

· Dougy Kevan (Norgine)

· Francois van der Merwe (Novartis) Acting CEO

· Toni Hanekom – (Genzyme) Acting CEO

· Steve Hoerter (Roche)

· Corne van Steijn (Bristol-Myers Squibb)

· Wilna Stapelberg (Fresenius Kabi)

IMSA: Published Profile of Member Companies and Position Statements
Media Contact Person:

Val Beaumont - Executive Directive

IMSA Email: val@imsa.org.za

Tel: 011 880 4644

Fax: 011 880 5987

Val Beaumont Image

Contact Details:

Innovative Medicines SA
Val Beaumont

P.O. Box 2008
Houghton, 2041

Tel: +27 11 880-4644

Fax: +27 11 880-5987

Contact Us!

imsa_spacer_slash

imsa_spacer_slash
IMSA_Nvaigation_footer